Is Generic Mycophenolate Mofetil as Good as CellCept?All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication.
All of the generic versions of CellCept currently available have an "AB" rating, meaning they should be equivalent to CellCept.
However, generic medications are allowed to have different inactive ingredients than the brand-name drug. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.
When Will Generic CellCept Intravenous and Oral Liquid Be Available?
The first patent for CellCept oral liquid suspension is set to expire in November 2014. This is the earliest predictable date that generic versions of the oral liquid could become available.
However, other circumstances could come up to extend or shorten these exclusivity periods. This includes such things as lawsuits or other patents for new uses. Once these forms of CellCept go off-patent, there may be several companies that manufacture generic versions of the drug.
The patent for the intravenous injection already expired in September. No generics are yet available, for unclear reasons.
Is Mycophenolate a Generic CellCept?No -- mycophenolate is the active ingredient in CellCept, but it is not a generic version of the medication. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.